DistantNews
Support us
๐Ÿ‡ธ๐Ÿ‡ฆ Saudi Arabia /Health & Science

AI-trained dogs in India sniff out cancer in experimental screening effort

From Asharq Al-Awsat · () English

Translated from English and summarized by DistantNews. Read the original for the full story.

At a glance

In-depth Named sources Context piece
  • A Bengaluru startup is using dogs fitted with sensor-equipped gear and AI analysis to study whether their reactions to human breath can help detect cancer.
  • Dognosis said a study of more than 1,500 participants recorded accuracy above 90 percent across seven major cancer types, but specialists called for larger trials.
  • The company hopes to launch commercially next year and develop an affordable first-stage screening tool for India.

Chloe spends her time between a farm outside Bengaluru and an unusual medical experiment. The Labrador mix wears a 3D-printed helmet and sensor-packed harness while learning to detect cancer in human breath.

In an hour, they can do thousands of sniffs.

· Akash KulgodDognosis co-founder describing the dogsโ€™ capacity during the experimental screening work.

She is one of 15 dogs trained by Dognosis, a Bengaluru startup that uses artificial intelligence to analyze the animalsโ€™ brain activity, breathing and body language. The goal is to convert their reactions to scents into data that could support a non-invasive cancer test.

Dogs can perform thousands of sniffs in an hour, said co-founder Akash Kulgod. โ€œEach sniff can evaluate a sample.โ€ Patients breathe into a cotton mask for about 10 minutes, after which the sealed mask goes to a laboratory. The patients do not meet the dogs.

Each sniff can evaluate a sample.

· Akash KulgodKulgod explained how the startup seeks to turn the dogsโ€™ scent reactions into medical data.

Dognosis says a recent study involving more than 1,500 people at six hospitals in Karnataka achieved accuracy above 90 percent across seven major cancer types. The study appeared in the Journal of Clinical Oncology, and the company plans to test the method in real-world programs while seeking commercial approval.

The study is promising, as an early signal.

· Santhosh Kumar DevadasThe oncology chief at Ramaiah Memorial Hospital offered cautious support for the study.

Cancer specialists not involved in the project struck a cautious note. Santhosh Kumar Devadas of Ramaiah Memorial Hospital called the study โ€œpromising, as an early signal,โ€ but said researchers needed a much larger group before drawing firm conclusions. Neelesh Reddy of Manipal Hospitals said, โ€œonly time will tell how this technology will be useful to the actual patientsโ€. Dognosis hopes the system could offer an affordable first layer of screening in India, where many patients receive diagnoses only after the disease has advanced.

only time will tell how this technology will be useful to the actual patients

· Neelesh ReddyA senior consultant oncologist at Manipal Hospitals said the technology still needed to prove its practical value.
About this summary

Originally published by Asharq Al-Awsat in English. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.